CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 30 enrolled
Drug / intervention
NMBM +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01770509
NCT01770509Phase 2Completed
CompareCT.gov

A Randomized, Parallel Group, Controlled Study to Assess the Efficacy and Safety of NMBM in the Treatment of Subjects With a Post-cellulitis and Venous Leg Ulcer

M.D. Lederman Consulting Ltd·interventional·Posted Jan 17, 2013·Updated Jan 11, 2017

In Brief

A Phase 2 clinical trial evaluating NMBM and Compression garments for Ulcer and 3 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Ulcers of the lower extremities, caused by chronic venous insufficiency and cellulitis are common in patients older than 65 years and cause a significant morbidity. Natural Matrix Bio polymer Membrane (NMBM) is a novel topical cosmetic cream containing a mix of natural waxes, sugars and lipids. The aim of this study is to test whether of Natural Matrix Bio polymer Membrane (NMBM) is effective as an adjunctive therapy to the treatment of venous stasis and post-erysipelas leg ulcers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUlcer, Venous Ulcer, Skin Ulcer, Leg Ulcer
CountriesIsrael
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 17, 2013
Enrollment StartFeb 1, 2013
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 13.5 years ago

Interventions

NMBMdevice

Daily application of NMBM in addition to compression therapy

Compression garmentsother

Compression garments